ABL Bio Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 20, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	3,930,320	11,025,033	1,443,630	1,178,156	1,099,129	1,041,424
Market Cap Growth	9.01%	663.70%	22.53%	7.19%	5.54%	-
Enterprise Value	3,799,742	10,941,258	1,335,337	1,126,398	1,038,936	-
Last Close Price	70200.00	200000.00	29900.00	24600.00	23000.00	22100.00
PE Ratio	-	-	-	-	342.55	-
Forward PE	15721.28	277.59	-	-	-	-
PS Ratio	43.51	138.94	43.22	17.97	16.33	195.31
PB Ratio	21.44	70.36	8.63	15.90	15.81	18.61
P/TBV Ratio	22.13	72.60	8.91	16.47	16.43	19.50
P/FCF Ratio	588.47	-	-	-	15.69	-
P/OCF Ratio	196.96	-	-	-	15.24	-
EV/Sales Ratio	42.07	137.89	39.98	17.18	15.44	-
EV/EBITDA Ratio	-	-	-	-	321.37	-
EV/EBIT Ratio	-	-	-	-	1144.20	-
EV/FCF Ratio	568.92	-	-	-	14.83	-
Debt / Equity Ratio	0.30	0.35	0.26	0.59	0.60	0.01
Debt / EBITDA Ratio	-	-	-	-	12.94	-
Debt / FCF Ratio	8.31	-	-	-	0.60	-
Net Debt / Equity Ratio	-0.73	-0.38	-0.58	-0.37	-0.52	-0.77
Net Debt / EBITDA Ratio	5.39	1.61	1.72	996.51	-11.28	0.88
Net Debt / FCF Ratio	-19.96	0.97	1.25	0.80	-0.52	1.03
Asset Turnover	0.36	0.31	0.17	0.38	0.54	-
Quick Ratio	1.67	1.41	2.24	1.71	1.09	5.01
Current Ratio	1.70	1.43	2.28	1.81	1.12	5.20
Return on Equity (ROE)	-14.95%	-23.38%	-46.01%	-3.69%	5.12%	-
Return on Assets (ROA)	-7.02%	-9.84%	-18.93%	-0.95%	0.45%	-
Return on Capital Employed (ROCE)	-15.50%	-25.70%	-35.20%	-2.20%	0.80%	-90.30%
Earnings Yield	-0.61%	-0.34%	-3.85%	-0.22%	0.29%	-4.18%
FCF Yield	0.17%	-0.56%	-5.43%	-2.90%	6.38%	-4.02%
Buyback Yield / Dilution	-10.68%	-7.25%	-0.37%	-0.58%	-1.27%	-